Efficacy and safety of minocycline in acute ischaemic stroke by time of first dose and onset-to-treatment time: a secondary analysis of the EMPHASIS trial

Background: Minocycline improved functional outcomes in EMPHASIS, but timing-related consistency is uncertain. We assessed treatment effects by first-dosing clock time and onset-to-first-dosing interval. Methods: EMPHASIS was a phase 3, multicentre, double-blind, randomised, placebo-controlled trial at 58 Chinese hospitals. Patients aged 18–80 years with acute ischaemic stroke within 72 h and NIHSS 4–25 were assigned 1:1 to oral minocycline or placebo. This prespecified subgroup analysis categorised first-dosing clock time as daytime, evening, or overnight, and onset-to-first-dosing interval as ≤24 h, >24–48 h, or >48 h. The primary outcome was 90-day mRS 0–1. Treatment-by-subgroup interactions were tested in adjusted models. Findings: Between May 19, 2023, and May 20, 2024, 1724 patients were assigned (862 per group). Minocycline increased 90-day mRS 0–1 versus placebo (447/850 [52·6%] vs 403/851 [47·4%]; absolute difference 5·2 percentage points, 95% CI 0·5–10·0; adjusted RR 1·14, 95% CI 1·03–1·25; P=0·012). No significant interaction was detected by first-dosing clock time (P for interaction=0·559) or onset-to-first-dosing interval (P for interaction=0·604). Symptomatic intracranial haemorrhage at 24 h occurred in one minocycline patient and none receiving placebo. Interpretation: We found no statistical evidence that minocycline effects differed by first-dosing clock time or onset-to-first-dosing interval within 72 h; these exploratory findings do not establish an optimal dosing time.

Authors

Institutions

Publication Details

Journal
EClinicalMedicine
Published
2026-11-14
DOI
https://doi.org/10.1016/j.eclinm.2026.104335
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Efficacy and safety of minocycline in acute ischaemic stroke by time of first dose and onset-to-treatment time: a secondary analysis of the EMPHASIS trial

Jean‐Paul Collet, Ling Guan, Tong Guo, Ziyi Gao et al.
3 links
EClinicalMedicine
Acute Ischemic Stroke Management
article

Efficacy and safety of minocycline in acute ischaemic stroke by time of first dose and onset-to-treatment time: a secondary analysis of the EMPHASIS trial

Jean‐Paul Collet, Ling Guan, Tong Guo, Ziyi Gao, Yilong Wang, Luyan Wang, David Wang, Yao Lu
article en

Abstract

Background: Minocycline improved functional outcomes in EMPHASIS, but timing-related consistency is uncertain. We assessed treatment effects by first-dosing clock time and onset-to-first-dosing interval. Methods: EMPHASIS was a phase 3, multicentre, double-blind, randomised, placebo-controlled trial at 58 Chinese hospitals. Patients aged 18–80 years with acute ischaemic stroke within 72 h and NIHSS 4–25 were assigned 1:1 to oral minocycline or placebo. This prespecified subgroup analysis categorised first-dosing clock time as daytime, evening, or overnight, and onset-to-first-dosing interval as ≤24 h, >24–48 h, or >48 h. The primary outcome was 90-day mRS 0–1. Treatment-by-subgroup interactions were tested in adjusted models. Findings: Between May 19, 2023, and May 20, 2024, 1724 patients were assigned (862 per group). Minocycline increased 90-day mRS 0–1 versus placebo (447/850 [52·6%] vs 403/851 [47·4%]; absolute difference 5·2 percentage points, 95% CI 0·5–10·0; adjusted RR 1·14, 95% CI 1·03–1·25; P=0·012). No significant interaction was detected by first-dosing clock time (P for interaction=0·559) or onset-to-first-dosing interval (P for interaction=0·604). Symptomatic intracranial haemorrhage at 24 h occurred in one minocycline patient and none receiving placebo. Interpretation: We found no statistical evidence that minocycline effects differed by first-dosing clock time or onset-to-first-dosing interval within 72 h; these exploratory findings do not establish an optimal dosing time.

EClinicalMedicineVol. 102
Beijing Institute of Technology (CN), Barrow Neurological Institute (US), St. Joseph's Hospital and Medical Center (US), University of British Columbia (CA), Capital Medical University (CN), Zhengzhou University (CN), Beijing Tian Tan Hospital (CN)
Good health and well-being
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon